Wouldn't many of the non-technical hurdles be reduced in the current situation? FDA approval steps for example have been relaxed for potential treatments. It's

Wouldn't many of the non-technical hurdles be reduced in the current situation? FDA approval steps for example have been relaxed for potential treatments. It's not my area, but I'm just curious what makes it so impossible or unlikely.